Publication | Closed Access

The adenosine A2A receptor antagonist, istradefylline enhances the anti-parkinsonian activity of low doses of dopamine agonists in MPTP-treated common marmosets

Functional SelectivityMedicineNeuropharmacologyMptp-treated Common MarmosetsPharmacotherapyNeuroscienceAnti-parkinsonian ActivityDopamine AgonistsExperimental PharmacologyDopaminePharmacology